Aperio Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-43,434
| Closed | -$781K | – | 2414 |
|
|
2020
Q2 | $781K | Buy |
43,434
+3,779
| +10% | +$68K | ﹤0.01% | 1537 |
|
|
2020
Q1 | $283K | Buy |
+39,655
| New | +$283K | ﹤0.01% | 1939 |
|
|
2019
Q4 | – | Sell |
-8,463
| Closed | -$227K | – | 2359 |
|
|
2019
Q3 | $227K | Buy |
8,463
+2,863
| +51% | +$76.8K | ﹤0.01% | 2130 |
|
|
2019
Q2 | $152K | Buy |
+5,600
| New | +$152K | ﹤0.01% | 2273 |
|
|
2018
Q1 | – | Sell |
-4,770
| Closed | -$232K | – | 2280 |
|
|
2017
Q4 | $232K | Buy |
4,770
+356
| +8% | +$17.3K | ﹤0.01% | 2082 |
|
|
2017
Q3 | $238K | Sell |
4,414
-44
| -1% | -$2.37K | ﹤0.01% | 2046 |
|
|
2017
Q2 | $250K | Buy |
+4,458
| New | +$250K | ﹤0.01% | 1992 |
|